36 results on '"Campieri, M."'
Search Results
2. Beclomethasone dipropionate versus mesalazine in distal ulcerative colitis: A multicenter, randomized, double-blind study
3. Probiotics — Role in inflammatory bowel disease
4. Intestinal microflora and oral bacteriotherapy in irritable bowel syndrome
5. P.08.17 SINGLE VS DUAL-CAMERA: A COMPARATIVE ANALYSIS OF COLON CAPSULE ENDOSCOPY TO EVALUATE THE SMALL BOWEL
6. P.08.18 A NEW DEDICATED CAPSULE FOR DIAGNOSIS AND MONITORING OF CROHN'S DISEASE. FIRS PATIENT SERIES
7. P.06.23: Capsule Endoscopy – Accuracy and Prognostic Value of Small Bowel Lesions in Patients with Crohn’s Disease
8. P.11.19: Maintenance of Deep Remission in Patients with Ulcerative Colitis Treated with Thiopurines after Withdrawal of the Drug: Perspective Real-Life Experience of a Single Center
9. OC.11.4 RE-GAIN OF RESPONSE IN CROHN'S DISEASE ADALIMUMAB (ADA) DOSE-ESCALATING FAILURE OR EARLY RELAPSE. A SINGLE CENTRE EXPERIENCE
10. P.08.2 THE LONG-TERM CLINICAL COURSE OF REFRACTORY CHRONIC POUCHITIS AFTER INFLIXIMAB THERAPY
11. P.01.2 ADALIMUMAB FOR THE TREATMENT OF POST-OPERATIVE RECURRENCE OF CROHN'S DISEASE. A SINGLE CENTRE EXPERIENCE
12. CS.02.3 ADALIMUMAB IN THE TREATMENT OF PERIANAL CROHN'S DISEASE: LONG TERM RESULTS IN A SINGLE TERTIARY CENTER
13. P.06.2 EFFICACY, SAFETY, IMPACT ON NATURAL HISTORY OF LONG-TERM TREATMENT WITH THIOPURINES IN CROHN'S DISEASE PATIENTS. A SINGLE CENTER EXPERIENCE
14. OC.06.2 LONG-TERM OUTCOME AFTER INFLIXIMAB TREATMENT FOR DISTAL REFRACTORY ULCERATIVE COLITIS. A SINGLE TERTIARY CENTER EXPERIENCE
15. P.05.8 ORAL BECLOMETHASONE DIPROPIONATE IN THE TREATMENT OF CHRONIC REFRACTORY POUCHITIS
16. PC.1.3: IL-33-DEPENDENT INDUCTION OF INTESTINAL PROFIBROTIC GENE EXPRESSION AND MYOFIBROBLAST HYPERTROPHY: POTENTIAL ROLE IN INFLAMMATORY-ASSOCIATED GUT FIBROSIS
17. P.1.23: CELL PROLIFERATION ACTIVITY OF OESOPHAGEAL SQUAMOUS EPITHELIUM IN ERD IS REDUCED COMPARED TO NERD
18. P.70 ADALIMUMAB IN THE TREATMENT OF PERIANAL CROHN'S DISEASE: A SINGLE CENTER EXPERIENCE IN 64 PATIENTS
19. OC.01.8 USE OF INFLIXIMAB AND ADALIMUMAB IN REFRACTORY POUCHITIS
20. P.17 ROLE OF CB1 IN THE EROSIVE AND NON-EROSIVE GASTRO-ESOPHAGEAL REFLUX DISEASE
21. OC.07.1 ADALIMUMAB IS EFFECTIVE IN THE TREATMENT OF ACTIVE LUMINAL CROHN'S DISEASE AND MUCOSAL HEALING: A SINGLE CENTER EXPERIENCE IN 170 PATIENTS
22. PP33 ADALIMUMAB DOES NOT INFLUENCE PITUITARY ADENOMA IN A CHILD WITH ACTIVE REFRACTORY CROHN'S DISEASE
23. 3 P Probiotic therapy as a prophylaxis in ileo-anal anastomosis patients decreases interferon gamma, interleukin 1 beta and interleukin 8 MRNA expression
24. 78 P High dose of probiotics is effective in the treatment of mild pouchitis. A pilot study
25. 79 OP Ileal pouch anal anastomosis: Pregnancy, delivery and pouch function
26. Oral beclomethasone dipropionate versus oral 5-aminosalicylic acid in the treatment of active ulcerative colitis: A randomised, 4 week, controlled study
27. Highly concentrated probiotics prevent pouchitis onset
28. Quality of life evaluation in patients with ulcerative colitis in a randomized clinical trial: Responsiveness and validity of a disease-specific questionnaire
29. Comparison of oral versus combination mesalazine therapy in active ulcerative colitis: A double-blind, double-dummy, randomized, multi-center Italian study
30. Prophylaxis of postoperative recurrence of Crohn's disease: Combination of antibiotic and probiotic versus mesalazine
31. Chemokine expression in pouchitis
32. Chemokine expression in pouchitis
33. Quality of life evaluation in patients with ulcerative colitis in a randomized clinical trial: Responsiveness and validity of a disease-specific questionnaire
34. Bacteria in pouch tissue
35. Refractory pouchitis: The role of wireless capsule endoscopy
36. Antibiotic treatment of active Crohn's disease: Results of a multicentre, double blind, randomised, placebo-controlled trial with rifaximin (Grace 01)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.